Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,450,000 shares, a decrease of 21.2% from the April 30th total of 3,110,000 shares. Approximately 16.0% of the shares of the stock are […]
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have issued a report on the stock […]
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Tourmaline Bio (NASDAQ:TRML) Issues Earnings Results themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tourmaline Bio (NASDAQ:TRML) Receives Buy Rating from HC Wainwright dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Vivo Capital LLC Purchases Shares of 591,882 Tourmaline Bio, Inc. (NASDAQ:TRML) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Rating of "Buy" from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]